Second-Quarter Consumer Health Results Bring J&J Relief From Year-Ago Sales Plummet
Segment's Results Likely Better Than Remainder Of 2021, J&J And Analyst Say
In first of what could be similar April-June earnings results from major consumer health firms, J&J reports 9.2% operational growth to $3.74bn in sales. Worldwide consumer health chief Thibaut Mongon touts segment’s results and outlook but says similar growth in second half isn’t assured.
You may also be interested in...
J&J Consumer Health's worldwide chairman Thibaut Mongon told the recent Barclays Consumer Staples conference that COVID-19 had accelerated the shift to digital and what consumers expect from OTC brands.
J&J's CEO Alex Gorsky is stepping down after almost 10 years in the role and will be replaced by vice chairman of the executive committee Joaquin Duato.
Duato has been involved for the last several years in growing J&J’s pharma and consumer businesses and has led the company’s COVID-19 efforts. Gorsky is stepping down due to a family health issue.